|
|
|
| A case report and literature review of perioperative management of laparoscopic cholecystectomy in patients with hemophilia |
| ZHOU Zheyu1 WANG Kai2 LIU Qiaoyu3 YIN Yin3 |
1.Department of General Surgery, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Jiangsu Province, Nanjing 210008, China;
2.Nanjing Drum Tower Clinical Medical College, Nanjing University of Chinese Medicine, Jiangsu Province, Nanjing 210008, China;
3.Department of Hepatobiliary Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Jiangsu Province, Nanjing 210008, China |
|
|
|
|
Abstract Hemophilia C (factor Ⅺ deficiency) is a rare coagulation dysfunction disorder. Spontaneous bleeding is rare in patients with hemophilia C, and significant bleeding usually occurs after trauma or surgical procedures. According to the literature review, there have been no reports of patients with hemophilia C undergoing laparoscopic cholecystectomy. The patient sought medical treatment due to “gallstone discovery for more than four years and intermittent dull pain in the abdomen for more than ten months”, and had a previous history of hemophilia C. Preoperative coagulation function examination showed that the activated partial thromboplastin time was significantly prolonged (67.4 s), and the factor Ⅺ activity was 2.4%. According to the consultation of hematology department, the patient was treated with fresh frozen plasma and tranexamic acid in perioperative period. In the end, the operation was successful, and there was no obvious bleeding during and after the operation. This case report suggests that it is safe for hemophilia C patients to receive laparoscopic cholecystectomy after symptomatic treatment, and can provide reference for clinical diagnosis and treatment of similar cases.
|
|
|
|
|
|
[1] Mohammed BM，Matafonov A，Ivanov I，et al. An update on factor Ⅺ structure and function [J]. Thromb Res，2018，161：94-105.
[2] Rosenthal RL，Dreskin OH，Rosenthal N. New hemophilia- like disease caused by deficiency of a third plasma thromboplastin factor [J]. Proc Soc Exp Biol Med，1953，82（1）：171- 174.
[3] 中华医学会血液学分会血栓与止血学组，中国血友病协作组.罕见遗传性出血性疾病诊断与治疗中国专家共识（2021年版）[J].中华血液学杂志，2021，42（2）：89-96.
[4] Nakajima R，Togo A，Kanno Y，et al. Acquired Factor Ⅺ Deficiency with Lupus Anticoagulant in a Pregnant Woman Diagnosed by the Eruptions and Pain in Fingers [J]. Case Rep Obstet Gynecol，2020，2020：8854676.
[5] Wool GD，A Treml，JL Miller. Acquired factor Ⅺ deficiency and therapeutic plasma exchange [J]. J Clin Apher，2018，33（3）：427-430.
[6] Bortoli R，Monticielo OA，Chakr RM，et al. Acquired factor Ⅺ inhibitor in systemic lupus erythematosus--case report and literature review [J]. Semin Arthritis Rheum，2009，39（1）： 61-65.
[7] 杨仁池.血友病诊断与治疗中国专家共识（2017年版）[J].中华血液学杂志，2017，38（5）：364-370.
[8] Lewandowska MD，Connors JM. Factor Ⅺ Deficiency [J]. He- matol Oncol Clin North Am，2021，35（6）：1157-1169.
[9] Bauduer F，de Raucourt E，Boyer-Neumann C，et al. Factor Ⅺ replacement for inherited factor Ⅺ deficiency in routine clinical practice：results of the HEMOLEVEN prospective 3-year postmarketing study [J]. Haemophilia，2015，21（4）：481-489.
[10] Puetz J. Fresh frozen plasma：the most commonly prescribed hemostatic agent [J]. J Thromb Haemost，2013，11（10）：1794-1799.
[11] Guo WJ，Chen WY，Yu XR，et al. Intraoperative thromboelastography-guided transfusion in a patient with factor Ⅺ deficiency：A case report [J]. World J Clin Cases，2022，10（1）：242-248.
[12] Burgos Pratx LD，Santoro DM，Mileo FG，et al. Management of factor Ⅺ deficiency in oncological liver and colorectal surgery by therapeutic plasma exchange：A case report [J]. Transfus Apher Sci，2021，60（5）：103176.
[13] Palla R，Peyvandi F，Shapiro AD. Rare bleeding disorders：diagnosis and treatment [J]. Blood，2015，125（13）：2052- 2061.
[14] Burton AG，Jandrey KE. Use of Thromboelastography in Clinical Practice [J]. Vet Clin North Am Small Anim Pract，2020，50（6）：1397-1409.
[15] Min J，Wan P，Liu G，et al. Sonoclot Signature Analysis：A New Point-of-Care Testing Method for Defining Heat Stroke- Induced Coagulopathy [J]. Int J Gen Med，2021，14：6925- 6933.
[16] Vandenheuvel M，VAN Gompel C，Vandewiele K，et al. Comparison of coagulation monitoring using ROTEM and Sonoclot devices in cardiac surgery：a single-center prospective observational study [J]. Minerva Anestesiol，2022，88（9）：680-689.
[17] Fredenburgh JC，Weitz JI. Factor Ⅺ as a Target for New Anticoagulants [J]. Hamostaseologie，2021，41（2）：104-110.
[18] Gailani D. Making anticoagulation safer [J]. Lancet，2022， 399（10333）：1360-1361.
[19] Yi BA，Freedholm D，Widener N，et al. Pharmacokinetics and pharmacodynamics of Abelacimab （MAA868），a novel dual inhibitor of Factor Ⅺ and Factor Ⅺa [J]. J Thromb Hae- most，2022，20（2）：307-315.
[20] Piccini JP，Caso V，Connolly SJ，et al. Safety of the oral factor Ⅺa inhibitor asundeⅪan compared with apixaban in patients with atrial fibrillation （PACIFIC-AF）：a multicentre，randomised，double-blind，double-dummy，dose-finding phase 2 study [J]. Lancet，2022，399（10333）：1383- 1390.
[21] Kazui T，Nielsen VG，Audie SD，et al. A Case Report of Severe Factor Ⅺ Deficiency during Cardiac Surgery：Less Can Be More [J]. J Cardiovasc Dev Dis，2022，9（4）：118.
[22] Guadalix-Sanchez C，Albajar-Bobes A，Barbero-Mielgo M，et al. Hemophilia C management in obstetric anesthesia [J]. Saudi J Anaesth，2022，16（1）：111-113.
[23] Murray NP，Ilabaca J，Guzman E，et al. Management of mild congenital deficiency of Factor Ⅺ with a Factor Ⅺ inhibitor in pregnancy：A clinical case [J]. Hematol Transfus Cell Ther，2022，44（3）：444-446.
[24] Serikyaku H，Higa S，Yara T，et al. Factor Ⅺ Deficiency in a Patient with Cervical Spondylotic Myelopathy [J]. Spine （Phila Pa 1976），2021，46（5）：E349-E352.
[25] Young JR，Roberts J. Conversion Total Hip Arthroplasty Following Failed Hip Fracture Fixation in a Patient with Factor Ⅺ Deficiency：A Case Report [J]. J Orthop Case Rep，2020，10（3）：80-84. |
|
|
|
